ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

YMAB Y mAbs Therapeutics Inc

11.55
0.28 (2.48%)
11 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Y mAbs Therapeutics Inc NASDAQ:YMAB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.28 2.48% 11.55 11.33 16.21 11.565 10.91 11.29 219,689 00:12:45

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Y-mAbs Therapeutics, Inc. - YMAB

09/03/2023 3:50am

PR Newswire (US)


Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart


From Jul 2022 to Jul 2024

Click Here for more Y mAbs Therapeutics Charts.

CEDARHURST, N.Y., March 8, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Y-mAbs Therapeutics, Inc. (NasdaqGS: YMAB), if they purchased the Company's securities between October 6, 2020 and October 28, 2022, inclusive (the "Class Period"), including shares of Rodgers Silicon prior to July 15, 2021.  Shareholders have until March 20, 2023 to file lead plaintiff applications in the securities class action lawsuit.

KZ Law (PRNewsfoto/Kuznicki Law PLLC)

Shareholders are encouraged to contact us at https://kclasslaw.com/cases/securities/nasdaqgs-ymab/, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com).

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
https://kclasslaw.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/filing-deadline--kuznicki-law-pllc-announces-class-action-on-behalf-of-shareholders-of-y-mabs-therapeutics-inc---ymab-301767459.html

SOURCE Kuznicki Law PLLC

Copyright 2023 PR Newswire

1 Year Y mAbs Therapeutics Chart

1 Year Y mAbs Therapeutics Chart

1 Month Y mAbs Therapeutics Chart

1 Month Y mAbs Therapeutics Chart

Your Recent History

Delayed Upgrade Clock